Tern Plc – Device Authority new contract win valued at over US$1.2 million

TERN

Tern Plc (LON:TERN), the company focused on value creation from Internet of Things technology businesses, has noted that Device Authority Limited has expanded its business and technology relationship with an existing tier one automotive supply chain customer via a new contract win valued at over US$1.2 million over five years, for expanded deployment of Device Authority’s KeyScaler® technology. Tern holds 53.8% of Device Authority’s equity.

This broader adoption of Device Authority’s KeyScaler® platform will enable this automotive supply chain customer to transform their long-term usage of the platform to develop a ‘secure identities’ manufacturing model for use across its global factories, positioning Device Authority as a key strategic partner for the customer, working collaboratively over the longer term.

Device Authority’s agreement with the global automotive supplier follows a contract secured by Device Authority in November 2022, in partnership with key strategic channel partners, with one of Europe’s main energy providers. This agreement will see Device Authority’s KeyScaler® platform integrated with existing and new services, providing identity management services for existing and next generation connected infrastructure. The contract has a projected value for Device Authority of approximately US$500,000 over the next three years, with the objective of protecting the energy company’s customers from cyber and ransomware attacks by providing trust for their IoT devices.

Commenting Al Sisto, CEO of Tern, said:

“We are delighted with the rapid progress that Device Authority is making in growing its revenue base, particularly via long term contracts with industry leaders.  The previous hard-fought wins with these leading companies are now being transformed into multi-year agreements.  Device Authority is validating the industry recognition it has already received from groups such as ABI Research* with these significant new contract wins, which will help them remain an industry leader in IoT device identity lifecycle management.

“2022 is proving to be a pivotal year for Device Authority following the strategic investment from Venafi in December 2021.  Tern and its co-investors are very pleased to see Device Authority enter into expanded multi-year agreements with some of the world’s leading IoT technology companies who are taking advantage of the features in Device Authority’s KeyScaler® platform to help provide significant long-term benefits to their customers.”

Note:

*https://www.abiresearch.com/market-research/product/7779608-iot-device-identity-lifecycle-management/

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

AI control of machines raises new security questions

AI is gaining the ability to control physical equipment, but establishing that machines are genuine, authorised and secure will be an important part of making this technology safe to deploy.

CAR-T therapy brings new approach to multiple myeloma treatment

CAR-T therapy is being used in multiple myeloma and is being studied earlier in the treatment pathway, with research focused on improving durability, safety and access.

Tern cuts H1 loss by 60% as portfolio growth and funding strengthen

Tern reduced its first-half loss by 60%, with net asset value improving and further fundraising strengthening the balance sheet. Additional funding has supported Talking Medicines and Device Authority, while continued progress across the portfolio provides further scope for value creation.

AI control of machines creates a new market for device trust

AI is beginning to control physical machines, increasing demand for technology that can verify device identity before those machines are allowed to act.

Peptide drug development expands beyond GLP-1

GLP-1 success is widening interest in peptide drug development, with the next phase focused on proving clinical value across new therapeutic areas.

Tern Plc announces 90% take-up of Open Offer

Tern Plc has received valid acceptances for 50.9 million Open Offer Shares, representing approximately 90% of the shares available. The fully underwritten offer will raise approximately £509,368 before expenses, with admission of the new shares expected on 24 September 2026.

Search